Article info

Download PDFPDF

Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients
  1. Mike Aristides, Director, M-TAG, PO Box 5639, Chatswood, NSW 2057, Australia.
View Full Text

Citation

Aristides M, Gliksman M, Rajan N, et al
Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients

Publication history

  • Accepted June 27, 1997
  • First published January 1, 1998.
Online issue publication 
January 01, 1998

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.